ReviewMagnetic resonance letters2027
The perspective of artificial intelligence for NMR.
Review in Magnetic resonance letters, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nuclear magnetic resonance (NMR) spectroscopy is an indispensable analytical technique in chemistry, biology, and medicine, offering molecular-level structural and dynamic insights for metabolite identification and biomarker discovery in biological and clinical research. However, its broader application in metabolite research is constrained by inherent limitations such as low sensitivity, severe peak overlap, and the trade-off between portability of low-field instruments and spectral resolution and sensitivity, as well as the difficulty of mining valid biological information from high-throughput metabolite big data. Recent advancements in artificial intelligence (AI), particularly deep learning (DL), have contributed to addressing these core challenges, reshaping the capabilities of NMR technology in metabolite research. This perspective overviews NMR's core role and existing metabolite-specific bottlenecks, and traces the evolutionary progress of AI in NMR. Then it focuses on three interrelated and technologically innovative directions of AI-powered NMR for metabolite, including (1) improving the spectral resolution of low-field spectra to match that of high-field spectra, or directly extracting high-field-like NMR information from low-field spectra; (2) mitigating spectral congestion via optimizing pure shift spectra of complex metabolic mixtures, which simplifies complex spectra by converting multiplets into singlets; and (3) identifying metabolites and biomarkers (including lipoprotein-related metabolic markers in hyperlipidemia) in metabolomics. The synergy of AI and NMR is poised to unlock unprecedented analytical capabilities for metabolomics, extending its impact across scientific discovery, precision medicine, food science, and other related fields.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.